weight regain after stopping tirzepatide Trajectory of cessation of GLP-1 receptor agonists: a systematic review and meta-regression People who stop taking weight-loss

Today, however, some users may cycle on and off the drugs every few months, or microdose, to get the benefits of the medication without the side effectsor to better manage the high cost of the drugs

A growing number of clinical studies investigate dementia risk between users of different glucose-lowering medications

Both Ozempic and the generic semaglutide products are approved by Health Canada for management of diabetes, but for years doctors prescribed it off-label for weight loss before manufacturer Novo Nordisk began selling Wegovy in Canada in 2024

Staying hydrated supports metabolic function

Zhao, M.-M

GALLIPOLIS, Ohio The use of GLP-1 medications such as Ozempic, Wegovy, Mounjaro and Zepbound continues to grow across Southeast Ohio and Southern West Virginia as more patients seek treatment for Type 2 diabetes and obesity, two chronic health conditions that remain prevalent throughout Appalachia